SOUTH SAN FRANCISCO, CA--(Marketwire - January 23, 2008) - Theravance, Inc. (NASDAQ: THRX) today announced that it closed the sale of its previously announced underwritten public offering of $172.5 million aggregate principal amount of unsecured 3% convertible subordinated notes due 2015, which includes the full exercise of the underwriters' over-allotment option for $22.5 million aggregate principal amount of notes.
